Sandoz in oncology biosimilar deal with China’s Bio-Thera 08-Sep-2021 By Jane Byrne Biosimilar producer, Sandoz, has entered into a commercialization agreement for biosimilar, BAT1706, referencing Avastin (bevacizumab) with Bio-Thera Solutions for the treatment of multiple types of cancers.